VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

The biosimilar regulatory pathway

Paul Cornes

How is the use of a biosimilar approved? What do regulators look for? How do they guarantee their safety? Paul Cornes, MD from the University Hospital Bristol NHS Foundation Trust, Bristol, UK talks about the biosimilars regulatory pathway.

More from Paul Cornes

4:34
Extrapolation - safely approving biosimilars for different indications
Paul Cornes
2:24
Are biosimilars as efficacious as their reference drugs?
Paul Cornes • 22 Jun 2017
2:43
Why do we need biosimilars?
Paul Cornes
3:30
Are biosimilars similar enough?
Paul Cornes
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals